Market Tracker

02/12 6:53am ET

Mesoblast Ltd (NASDAQ:MESO)

4.39
Delayed Data
As of Feb 11
 -0.02 / -0.45%
Today’s Change
4.26
Today|||52-Week Range
17.08
-30.97%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close4.41
Today’s open4.40
Day’s range4.26 - 4.96
Volume19,295
Average volume (3 months)69,194
Market cap$294.5M
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)-33.20%
Earnings growth (this year)+4.67%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+13.25%
P/E ratio--
Price/Sales54.36
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
CFMSConforMIS Inc-0.66-7.21%
RTIXRTI Surgical Inc+0.02+0.68%
VASCVascular Solutions I...-0.72-2.82%
AAVLAvalanche Biotechnol...+0.18+3.94%
Data as of 02/11/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$17.1M
Annual profit (last year)-$99.4M
Net profit margin-582.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Executive Director &
MD
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts